ImmunogenX Acquires Alvine Pharmaceuticals for Undisclosed Sum

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4ee9d18b-4d01-4e2e-8df2-d4376a59cb4f
Date
3/16/2016
Company Name
Alvine Pharmaceuticals
Mailing Address
75 Shoreway Rd San Carlos, CA 94070 USA
Company Description
Alvine Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to developing and commercializing therapeutics for the treatment of Celiac sprue.
Website
http://www.alvinepharma.com
Transaction Type
M&A
Transaction Amount
Undisclosed
Transaction Round
Proceeds Purposes
M&A Terms
The asset acquired was Latiglutenase (formerly known as ALV003 and renamed IMGX-003), an orally administered mixture of two recombinant gluten-specific proteases that degrades gluten proteins into small physiologically irrelevant fragments.